Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2017
Event	1st European Alliance for Personalised Medicine Congress 2017 - Belfast, United Kingdom Duration: 25 Nov 2017 → 30 Nov 2017

Conference	1st European Alliance for Personalised Medicine Congress 2017
Country/Territory	United Kingdom
City	Belfast
Period	25/11/2017 → 30/11/2017

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

Integration of class 1 HDAC inhibitors into current treatments for prostate cancer
Manley, J. (Author), LaBonte Wilson, M. (Supervisor) & Waugh, D. (Supervisor), Dec 2020
Student thesis: Doctoral Thesis › Doctor of Philosophy

@conference{35c1fbafbd71423198c75eda0c9c51ee,

title = "Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy",

keywords = "Prostate Cancer, Epigenetic, Entinostat",

author = "Judith Manley and Pamela Maxwell and Daniel Longley and David Waugh and {LaBonte Wilson}, Melissa",

year = "2017",

language = "English",

note = "1st European Alliance for Personalised Medicine Congress 2017 ; Conference date: 25-11-2017 Through 30-11-2017",

}

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Expanding the potential for epigenetic targeting therapies in prostate cancer

T2 - 1st European Alliance for Personalised Medicine Congress 2017

AU - Manley, Judith

AU - Maxwell, Pamela

AU - Longley, Daniel

AU - Waugh, David

AU - LaBonte Wilson, Melissa

PY - 2017

Y1 - 2017

KW - Prostate Cancer

KW - Epigenetic

KW - Entinostat

M3 - Poster

Y2 - 25 November 2017 through 30 November 2017

ER -